Publication | Closed Access
Phase I studies of AVE9633, an anti-CD33 antibody-maytansinoid conjugate, in adult patients with relapsed/refractory acute myeloid leukemia
104
Citations
10
References
2011
Year
Hematological MalignancyMedicineAdult PatientsImmunologyHematologyMyeloid NeoplasiaAdult T-cell Leukemia-lymphomaImmunotherapyOncologyRadiation OncologyAnti-cd33 Antibody-maytansinoid ConjugateCancer ResearchHealth Sciences
| Year | Citations | |
|---|---|---|
Page 1
Page 1